Alternatives to The Edit

Pallas is one of the few places that will sell you either the cheap compounded route or the real brand-name pen without making you pick a provider first — compounded semaglutide works out to about $199 a month and tirzepatide about $299, while actual Zepbound, Ozempic, Wegovy and Mounjaro sit alongside them at cash-pay prices from $1,069. The price genuinely doesn't climb as you titrate, Pallas says so plainly on its own site, and the clinician, dose adjustments, check-ins and messaging are all inside that one number with no membership fee stacked on top. Two clinicians are named and both check out in the federal NPI registry, the LegitScript badge it displays is a real one, and it publishes an actual refund policy — full refund if a clinician turns you down, and a $5 processing fee if you cancel a qualifying payment — which is more paperwork than most of this market bothers with. The two things to know before you commit: it bills every 12 weeks in $597 and $897 chunks rather than monthly, and it never names its compounding pharmacy.

The broadest GLP-1 menu I've found anywhere — brand Zepbound and Wegovy, two GLP-1 pills, and three compounded molecules — from doctors who actually specialize in midlife hormones, with one mandatory $99 fee sitting quietly on top of every price it advertises.

The price-first pick: some of the lowest flat, all-inclusive pricing I found, in all 50 states — great if the monthly number is your whole decision and you read the annual-prepay fine print before you sign.

A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it won't name.

A LegitScript-verified compounded option with a named medical team, all-50 coverage, and no subscription — semaglutide starts at $199, though it's one of several near-identical white-label sibling brands.

The only provider on my list that behaves like an actual doctor's office — in-network with most commercial plans and Medicare, dietitians and coaches built in, and every self-pay price published down to the dose — as long as you can get to a booked appointment every month at the start.

Luvo Health is the rare provider that publishes its whole price list — every program, every plan length — before asking you for anything, and then sells almost everything: semaglutide as an injection at $249 or tablets at $279, tirzepatide at $339, a genuine low-dose microdosing tier at $179 for either molecule, and real FDA-approved Ozempic and Zepbound at $1,299 and $1,399 for anyone who wants the on-label product. Twelve-week plans bring the injections down to about $219 and $309 a month. Its LegitScript certification is real — the seal ID returns a live image where an invented one errors — and it commits to not charging you if a clinician decides you aren't eligible. Two things hold it back. It never names the pharmacy that compounds any of this, which is a step behind the providers that do. And its own affiliate program is registered as a peptides and longevity offer that lands on a NAD+ and sermorelin page by default, so the weight-loss side of the business is the part it markets least.

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

Four flat, posted price points and a written promise your cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.